Angiotensin mediates renal fibrosis in the nephropathy of glycogen storage disease type Ia

Kidney International

Volumn 73, Issue 6, 2008, Pages 716-723

  Yiu, W H ^a   Pan, C J ^a   Ruef, R A ^a   Peng, W T ^a   Starost, M F ^b   Mansfield, B C ^a,c   Chou, J Y ^a,b  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c NONE   (United States)

Author keywords

Angiotensin; Connective tissue growth factor; Glycogen storage disease type Ia; Renal fibrosis; Transforming growth factor 1

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSINOGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGEN TYPE 4; CONNECTIVE TISSUE GROWTH FACTOR; FIBRONECTIN; SCLEROPROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; GLYCOGEN STORAGE DISEASE TYPE 1; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; KIDNEY FIBROSIS; KIDNEY TUBULE BASEMENT MEMBRANE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS;

EID: 40049110258     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5002718     Document Type: Article

References (48)

1. J.Y. Chou D. Matern B.C. Mansfield Y.T. Chen Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex Curr Mol Med 2 2002 121 143
2. E. von Gierke Hepato–nephro-megalia glycogenica (Glykogenspeicher-krankheit der Leber und Nieren) Beitr Pathol Anat 82 1929 497 513
3. Y.T. Chen R.A. Coleman J.I. Scheinman Renal disease in type I glycogen storage disease N Engl J Med 318 1988 7 11
4. R. Verani J. Bernstein Renal glomerular and tubular abnormalities in glycogen storage disease type I Arch Pathol Lab Med 112 1988 271 274
5. L. Baker S. Dahlem S. Goldfarb Hyperfiltration and renal disease in glycogen storage disease, type I Kidney Int 35 1989 1345 1350
6. H.L. Greene A.E. Slonim J.A. O'Neill Jr I.M. Burr Continuous nocturnal intragastric feeding for management of type 1 glycogen-storage disease N Engl J Med 294 1976 423 425
7. Y.T. Chen M. Cornblath J.B. Sidbury Cornstarch therapy in type I glycogen storage disease N Engl J Med 310 1984 171 175
8. D.A. Weinstein M.J. Somers J.I. Wolfsdorf Decreased urinary citrate excretion in type 1a glycogen storage disease J Pediatr 138 2001 378 382
9. J.P. Rake G. Visser P. Labrune Glycogen storage disease type I: diagnosis, management, clinical course and outcome. Results of the European Study on Glycogen Storage Disease type I (ESGSD I) Eur J Pediatr 161 Suppl 1 2002 S20 S34
10. Y.T. Chen Type I glycogen storage disease: kidney involvement, pathogenesis and its treatment Pediatr Nephrol 5 1991 71 76
11. B.F. Schrijvers A.S. De Vriese A. Flyvbjerg From hyperglycemia to diabetic kidney disease: the role of metabolic, hemodynamic, intracellular factors and growth factors/cytokines Endocr Rev 25 2004 971 1010
12. G. Wolf New insights into the pathophysiology of diabetic nephropathy: from haemodynamics to molecular pathology Eur J Clin Invest 34 2004 785 796
13. M. Eikmans J.J. Baelde E. de Heer J.A. Bruijn ECM homeostasis in renal diseases: a genomic approach J Pathol 200 2003 526 536
14. H.W. Schnaper J.B. Kopp Renal fibrosis Front Biosci 8 2003 68 86
15. G. Wolf Renal injury due to renin–angiotensin–aldosterone system activation of the transforming growth factor-beta pathway Kidney Int 70 2006 1914 1919
16. S. Kim H. Iwao Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases Pharmacol Rev 52 2000 11 34
17. S. Klahr J.J. Morrissey The role of vasoactive compounds, growth factors and cytokines in the progression of renal disease Kidney Int 75 Suppl 2000 S7 S14
18. S.A. Mezzano M. Ruiz-Ortega J. Egido Angiotensin II and renal fibrosis Hypertension 38 2001 635 638
19. M. Ruiz-Ortega M. Ruperez V. Esteban Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases Nephrol Dial Transplant 21 2006 16 20
20. G. Guron P. Friberg An intact renin–angiotensin system is a prerequisite for normal renal development J Hypertens 18 2000 123 137
21. S. Kagami W.A. Border D.E. Miller N.A. Noble Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells J Clin Invest 93 1994 2431 2437
22. E.P. Bottinger M. Bitzer TGF-beta signaling in renal disease J Am Soc Nephrol 13 2002 2600 2610
23. S. Chen B. Jim F.N. Ziyadeh Diabetic nephropathy and transforming growth factor-beta: transforming our view of glomerulosclerosis and fibrosis build-up Semin Nephrol 23 2003 532 543
24. Y. Liu Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention J Am Soc Nephrol 15 2004 1 12
25. B.C. Liu J. Sun Q. Chen Role of connective tissue growth factor in mediating hypertrophy of human proximal tubular cells induced by angiotensin II Am J Nephrol 23 2003 429 437
26. S. Gupta M.R. Clarkson J. Duggan H.R. Brady Connective tissue growth factor: potential role in glomerulosclerosis and tubulointerstitial fibrosis Kidney Int 58 2000 1389 1399
27. H. Ihn Pathogenesis of fibrosis: role of TGF-beta and CTGF Curr Opin Rheumatol 14 2002 681 685
28. C.J. Pan K.J. Kei H. Chen Ontogeny of the murine glucose-6-phosphatase system Arch Biochem Biophys 358 1998 17 24
29. M. Mazzali J. Hughes Y.G. Kim Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism Hypertension 38 2001 1101 1106
30. D.H. Kang T. Nakagawa L. Feng A role for uric acid in the progression of renal disease J Am Soc Nephrol 13 2002 2888 2897
31. S.L. Zhang J.G. Filep T.C. Hohman Molecular mechanisms of glucose action on angiotensinogen gene expression in rat kidney proximal tubular cells Kidney Int 55 1999 454 464
32. K.J. Lei H. Chen C.J. Pan Glucose-6-phosphatase dependent substrate transport in the glycogen storage disease type 1a mouse Nat Genet 13 1996 203 209
33. M. de Gasparo K.J. Catt T. Inagami International union of pharmacology. XXIII. The angiotensin II receptors Pharmacol Rev 52 2000 415 472
34. W.G. Thomas H. Qian Arresting angiotensin type 1 receptors Trends Endocrinol Metab 14 2003 130 136
35. L.M. Ruilope D.J. van Veldhuisen E. Ritz T.F. Luscher Renal function: the Cinderella of cardiovascular risk profile J Am Coll Cardiol 38 2001 1782 1787
36. M. Urushihara S. Kagami M. Ito Transforming growth factor-beta in renal disease with glycogen storage disease I Pediatr Nephrol 19 2004 676 678
37. H. Ha M.R. Yu H.B. Lee High glucose-induced PKC activation mediates TGF-beta 1 and fibronectin synthesis by peritoneal mesothelial cells Kidney Int 59 2001 463 470
38. X. Liu F. Luo K. Pan High glucose upregulates connective tissue growth factor expression in human vascular smooth muscle cells BMC Cell Biol 8 2007 1 12
39. B.L. Riser P. Cortes Connective tissue growth factor and its regulation: a new element in diabetic glomerulosclerosis Ren Fail 23 2001 459 470
40. J.M. Forbes K. Fukami M.E. Cooper Diabetic nephropathy: where hemodynamics meets metabolism Exp Clin Endocrinol Diabetes 115 2007 69 84
41. L. Castano G.S. Eisenbarth Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat Annu Rev Immunol 8 1990 647 679
42. S.I. Taylor Insulin action, insulin resistance, and type 2 diabetes mellitus Scriver C.R. Beaudet A.L. Sly W.S. Valle D. Childs B. Kinzler K.W. Vogelstein B. The Metabolic and Molecular Bases of Inherited Disease 8th edn. 2001 McGraw-Hill Inc. New York 1433 1469
43. N.D. Evcimen G.L. King The role of protein kinase C activation and the vascular complications of diabetes Pharmacol Res 55 2007 498 510
44. C.A. Leon L. Raij Interaction of haemodynamic and metabolic pathways in the genesis of diabetic nephropathy J Hypertens 11 2005 1931 1937
45. T. Nakagawa M. Mazzali D.H. Kang Hyperuricemia causes glomerular hypertrophy in the rat Am J Nephrol 23 2003 2 7
46. G. Nickenig S. Wassmann M. Bohm Regulation of the angiotensin AT1 receptor by hypercholesterolaemia Diabetes Obes Metab 2 2000 223 228
47. E. Levy J. Letarte G. Lepage Plasma and lipoprotein fatty acid composition in glycogen storage disease type I Lipids 22 1987 381 385
48. S. Hoffmann D. Podlich B. Hahnel Angiotensin II type 1 receptor overexpression in podocytes induces glomerulosclerosis in transgenic rats J Am Soc Nephrol 15 2004 1475 1487